Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Ruxolitinib can cause a delayed skin reaction on the nose.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Stem cells could improve hair growth and new treatments for baldness are being researched.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Natural extracts may promote hair growth with fewer side effects than conventional treatments.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Abrocitinib may effectively treat Lichen Planopilaris.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Biologics and small molecules can effectively treat inflammatory nail disorders, but personalized treatment plans are important.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

JAK inhibitors show promise for treating various skin diseases.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.